Funda Meric-Bernstam, M.D., elected to National Academy of Medicine
Funda Meric-Bernstam, M.D., chair of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center, has been elected to the National Academy of Medicine (NAM) for her contributions to precision oncology, therapeutics development and biomarker discovery, and for leading practice-changing clinical trials.
The NAM, originally established as the Institute of Medicine in 1970 by the National Academy of Sciences...
